83 related articles for article (PubMed ID: 3012211)
41. Phenotypically distinct target cells for murine sarcoma virus and murine leukemia virus marrow transformation in vitro.
Greenberger JS
J Natl Cancer Inst; 1979 Feb; 62(2):337-48. PubMed ID: 216835
[TBL] [Abstract][Full Text] [Related]
42. Characterization of murine JAK2V617F-positive myeloproliferative disease.
Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
[TBL] [Abstract][Full Text] [Related]
43. Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.
Laker C; Gräning G; Kelso A; Stocking C; Ostertag W
J Exp Med; 1990 Aug; 172(2):447-56. PubMed ID: 2165126
[TBL] [Abstract][Full Text] [Related]
44. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).
Van Zant G; Shultz L
Exp Hematol; 1989 Feb; 17(2):81-7. PubMed ID: 2783574
[TBL] [Abstract][Full Text] [Related]
45. Effects of Rauscher murine leukemia virus on hemopoietic organ-derived clonogenic fibroblasts.
Brockbank KG; de Both NJ; Voerman JS; van der Haven M
Leuk Res; 1986; 10(4):413-8. PubMed ID: 2421108
[TBL] [Abstract][Full Text] [Related]
46. Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium.
Miller AC; Bonait-Pellie C; Merlot RF; Michel J; Stewart M; Lison PD
Mol Cell Biochem; 2005 Nov; 279(1-2):97-104. PubMed ID: 16283518
[TBL] [Abstract][Full Text] [Related]
47. A recombinant murine granulocyte/macrophage (GM) colony-stimulating factor derived from an inducer T cell line (IH5.5). Functional restriction to GM progenitor cells.
Kajigaya S; Suda T; Suda J; Saito M; Miura Y; Iizuka M; Kobayashi S; Minato N; Sudo T
J Exp Med; 1986 Oct; 164(4):1102-13. PubMed ID: 3489806
[TBL] [Abstract][Full Text] [Related]
48. Tumorigenicity of human hematopoietic cell lines in athymic nude mice.
Nilsson K; Giovanella BC; Stehlin JS; Klein G
Int J Cancer; 1977 Mar; 19(3):337-44. PubMed ID: 14896
[TBL] [Abstract][Full Text] [Related]
49. Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus.
Mager DL; Mak TW; Bernstein A
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1703-7. PubMed ID: 6940184
[TBL] [Abstract][Full Text] [Related]
50. Effects of tumor bearing on the dynamics of host hemopoietic cells.
Lala PK
Cancer Treat Rep; 1976 Dec; 60(12):1781-9. PubMed ID: 1026335
[TBL] [Abstract][Full Text] [Related]
51. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).
Mavilio F; Kreider BL; Valtieri M; Naso G; Shirsat N; Venturelli D; Reddy EP; Rovera G
Oncogene; 1989 Mar; 4(3):301-8. PubMed ID: 2468124
[TBL] [Abstract][Full Text] [Related]
52. Relationship between colony-stimulating activity and interferon production during infection.
Egan P; Cheers C
Immunology; 1990 Jun; 70(2):191-6. PubMed ID: 2115498
[TBL] [Abstract][Full Text] [Related]
53. Human colony-stimulating activity-producing tumor: production of very low mouse-active colony-stimulating activity and induction of marked granulocytosis in mice.
Ikeda K; Motoyoshi K; Ishizaka Y; Hatake K; Kajigaya S; Saito M; Miura Y
Cancer Res; 1985 Sep; 45(9):4144-9. PubMed ID: 3875406
[TBL] [Abstract][Full Text] [Related]
54. Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines.
Nicola NA; Metcalf D
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3765-9. PubMed ID: 6610179
[TBL] [Abstract][Full Text] [Related]
55. Reconstitution of the W/Wv stem cell differentiation defect by infection with Rauscher leukemia virus.
Merchav S; Wagemaker G; van Bekkum DW
J Natl Cancer Inst; 1985 Aug; 75(2):361-8. PubMed ID: 3894753
[TBL] [Abstract][Full Text] [Related]
56. Induction of myeloid colony-stimulating activity in murine monocyte tumor cell lines by macrophage activators and in a T-cell line by concanavalin A.
Ralph P; Broxmeyer HE; Moore MA; Nakoinz I
Cancer Res; 1978 May; 38(5):1414-9. PubMed ID: 305822
[TBL] [Abstract][Full Text] [Related]
57. Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice.
Stoica G; Hoffman J; Yuen PH
Am J Pathol; 1990 Apr; 136(4):933-47. PubMed ID: 2158239
[TBL] [Abstract][Full Text] [Related]
58. [Granulocyte-macrophage colony enhancing factor activity in supernatant from murine myelo-monocytic leukemia cell line (WEHI-3B)--studies of target cell using hydroxyurea suicide technic].
Kajigaya Y; Ikuta K; Sasaki H; Koiso Y; Funabiki T; Matsuyama S
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):832-8. PubMed ID: 3061272
[No Abstract] [Full Text] [Related]
59. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
Welte K; Platzer E; Lu L; Gabrilove JL; Levi E; Mertelsmann R; Moore MA
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1526-30. PubMed ID: 3871951
[TBL] [Abstract][Full Text] [Related]
60. Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice.
Chang JM; Metcalf D; Gonda TJ; Johnson GR
J Clin Invest; 1989 Nov; 84(5):1488-96. PubMed ID: 2478588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
